Chemical industry – Page 78
-
FeatureReaching out
Andy Extance surveys how pharma uses outsourcing in a variety of different ways
-
Business
Mitsui continues reinvention efforts with two deals
Japanese firm drops organic acids in favour of lens materials
-
Business
Novartis enhances its focus with eyecare deal
Swiss firm buys rights to wet AMD drug from Ophthotech for up to $1bn
-
Business
AstraZeneca refuses Pfizer’s ‘final’ offer
Pfizer pledges not to make hostile bid direct to shareholders
-
NewsPrivatisation fears for UK environment body
Union warns research may be sidelined by commercial interests at the Food and Environment Research Agency
-
Business
Lilly protests $450m Brazilian fine
Firm says chemicals employees were allegedly exposed to were never used at site
-
Business
Chinese police hand GSK bribery case to prosecutors
Investigation alleges senior manager ordered staff to hand out bribes
-
BusinessPfizer presses hard for AstraZeneca deal
Executives face down international controversy over tax schemes and previous post-merger record
-
NewsPledge to create 2000 new STEM posts
UK government teams up with industry as part of campaign to inspire young people to take up science and engineering
-
Business
Solvay-Ineos PVC deal passes European approval
Firms required to divest plants to maintain competition
-
BusinessBayer wins race to buy Merck & Co consumer care
$14bn deal will make Aspirin inventor the number two over-the-counter healthcare company
-
Business
UK Lords urge government to take lead on fracking
Regulations holding back shale gas exploration, report says
-
CareersScience within Reach
Charlotte Ashley-Roberts explains what the Reach regulations could mean for you and your role
-
Business
UK regulator warning over online herbal remedies
Products found to contain toxic metals or undeclared prescription-only drugs
-
Business
Insider trading allegations stall Sun–Ranbaxy deal
Companies deny wrongdoing in lead-up to merger announcement
-
Business
Forest Labs buys Furiex for bowel drug
Firm will immediately sell on other assets to Royalty Pharma
-
Business
BASF to cut 260 jobs in nutrition and health
Firm to sell Norwegian site and shift focus towards Asia